NRIX
Nurix Therapeutics Inc
25.40$
-0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -3.0% | +799.8% | +20.3% | -12.6% | -14.7% | +88.2% | +2.8% | |
| – | -3.2% | +658.3% | +4.3% | +2.4% | -7.2% | +109.6% | -2.0% | |
| – | +36.0% | +242.8% | -32.5% | -19.9% | -15.3% | +101.4% | +124.5% | |
| – | -3.4% | +645.4% | +5.2% | +4.5% | -6.9% | +111.7% | -2.7% | |
| – | – | – | -45.3% | -82.3% | -27.3% | +87.5% | – | |
| – | – | – | – | -110,000,100.0% | – | – | – | |
| – | -12.5% | +72.4% | +279.9% | -32.3% | – | – | – | |
| – | +57.3% | +98.0% | +26.8% | -15.9% | +37.2% | -8.2% | +4.9% | |
| – | -50.8% | +176.0% | +48.8% | +6.6% | +23.1% | +10.2% | -9.8% | |
| – | +62.7% | +65.2% | -49.6% | +43.7% | +35.4% | +7.0% | -64.8% | |
| – | +23.2% | +113.5% | +94.9% | -23.8% | +26.4% | +79.4% | -2.3% | |
| – | – | – | +17.9% | -11.3% | -34.0% | +162.8% | +2.2% | |
| – | – | – | – | – | – | – | – | |
| – | +141.2% | -59.7% | +173.7% | +13.3% | +11.8% | +23.5% | +29.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.